A. Peter Thompson

Affiliations

  • Large Shareholder, Director at Edgewise Therapeutics Inc. (EWTX), 2021-03-31
  • Large Shareholder, Director at Decibel Therapeutics Inc. (DBTX), 2021-02-19
  • Large Shareholder, Director at Corvus Pharmaceuticals Inc. (CRVS), 2021-02-19
  • Large Shareholder, Director at Prevail Therapeutics Inc. (PRVL), 2021-01-26
  • Large Shareholder, Director at Alpine Immune Sciences Inc. (ALPN), 2021-01-06
  • Large Shareholder, Director at Silverback Therapeutics Inc. (SBTX), 2020-12-09
  • Large Shareholder, Director at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-29
  • Large Shareholder, Director at Synthorx Inc. (THOR), 2020-01-24
  • Director at Principia Biopharma Inc. (PRNB), 2018-09-13
  • Director at Adaptimmune Therapeutics Plc (ADAP), 2018-06-06
  • Large Shareholder, Director at Response Biomedical Corp (RBM), 2016-12-02
  • Director at Pronai Therapeutics Inc (DNAI), 2015-07-21
  • Director at Mirati Therapeutics Inc. (MRTX), 2013-07-12
  • Director at Anthera Pharmaceuticals Inc (ANTH), 2012-05-11
  • Officer, Director at Trubion Pharmaceuticals Inc (TRBN), 2009-05-26
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EWTX $16.00 312,500 Large Shareholder, Director 13,359,456 2021-03-30 Filing
EWTX $16.00 46,875 Large Shareholder, Director 319,599 2021-03-30 Filing
DBTX $18.00 555,566 Large Shareholder, Director 883,418 2021-02-17 Filing
DBTX $18.00 1,111,100 Large Shareholder, Director 3,843,206 2021-02-17 Filing
CRVS $3.50 1,285,714 Large Shareholder, Director 8,053,298 2021-02-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALPN $14.25 600,000 Large Shareholder, Director 3,070,955 2020-12-28 Filing
ADAP $13.49 1,600 Director 4,901,310 2018-06-06 Filing
ADAP $13.57 17,100 Director 4,902,910 2018-06-04 Filing
ADAP $13.49 50,000 Director 4,920,010 2018-06-01 Filing
ADAP $13.52 121,000 Director 4,970,010 2018-05-30 Filing